Night shifts may be linked to increased ovarian cancer risk

March 14, 2013

Working night shifts might increase the risk of developing ovarian cancer, indicates research published in Occupational and Environmental Medicine.

The risk may be lower for night types ("") than for morning types ("larks"), the findings suggest (see accompanying commentary).

The authors base their findings on 1101 women with the most common type (epithelial) of advanced ; 389 with borderline disease; and a comparison group of 1832 women without ovarian cancer.

The women, who were all aged between 35 and 74, were asked about the hours they worked, including whether they had ever worked night shifts.

The International Agency for Research on Cancer (IARC) has classified that disrupts the body's normal time clock (circadian ) as a cancer causing agent. And other research has suggested that shift work may be associated with an increased risk of breast cancer.

Among the women with , around 1 in 4 (26.6%; 293) had ever worked nights, compared with 1 in 3 (32.4%; 126) of those with borderline disease and around 1 in 5 (22.5%; 412) of the comparison group.

Use of the Pill was lower among women with ovarian cancer, who also tended to have had fewer children than those without the disease. Being on the Pill and are known to lower the risk of ovarian cancer.

The stint of night shifts averaged between 2.7 and 3.5 years across all three groups of women, with jobs in healthcare, and service, and office and admin support the most common types of employment.

Working night shifts was associated with a 24% increased risk of advanced cancer and a 49% increased risk of early stage disease compared with those who worked normal office hours.

A greater proportion (27%) of women who described themselves as "owls" had worked night shifts than women (20%) who were "larks".

The risks of either advanced ovarian cancer were slightly higher (29%) among "larks" than among "owls" (14%), although difference this was not statistically significant. Findings were similar for borderline tumours - 57% and 43% for "larks" and "owls," respectively.

Only women aged 50 and above were significantly more likely to have ovarian cancer if they had worked nights.

The authors say their findings are consistent with, and of a similar magnitude, as those found for , but point out that they did not find any cumulative risk for ovarian cancer the longer a woman had worked a night shift pattern.

One possible explanation could be linked to melatonin, a powerful hormone that is normally produced at night, but suppressed by ambient light, and which regulates reproductive hormones, particularly oestrogen.

Melatonin also scavenges harmful free radicals and boosts production of other antioxidants in the body.

Explore further: Does night work put women's health at risk?

More information: Nightshift work and risk of ovarian cancer, doi: 10.1136/oemed-2012-101146

Editorial: Shift work and cancer research: can chronotype predict susceptibility in night-shift and rotating-shift workers? Doi: 10.1136/oemed-2012-100984

Related Stories

Does night work put women's health at risk?

June 19, 2012
Breast cancer is the number one cause of female mortality. It affects 100 out of 100,000 women per year in developed countries. Each year, more than 1.3 million new cases are diagnosed, 53,000 of these in France.

Night shift might boost women's breast cancer risk: study

May 29, 2012
(HealthDay) -- Women who work the night shift more than twice a week might be increasing their risk for breast cancer, Danish researchers find.

Study links endometriosis with increased risk of developing 3 specific types of ovarian cancer

February 21, 2012
Women with a history of endometriosis are significantly more likely to develop three specific types of ovarian cancer (clear cell, endometrioid, and low-grade serous), according to an article published Online First in the ...

Rotating night shift work linked to increased risk of Type 2 diabetes in women

December 6, 2011
Women who work a rotating (irregular) schedule that includes three or more night shifts per month, in addition to day and evening working hours in that month, may have an increased risk of developing type 2 diabetes when ...

Pill and pregnancy have biggest effects on ovarian cancer risk

October 26, 2011
(Medical Xpress) -- Taking the Pill for 10 years can reduce the risk of ovarian cancer by almost half (45 per cent), new research part-funded by Cancer Research UK shows today.

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.